Durham-based 410 Medical has received up to nearly $2 million in U.S. military funding to develop two new versions of LifeFlow, its medical device for treating life-threatening low blood pressure, shock and sepsis in critically ill patients.
Target RWE Acquires NoviSci, Gains Amgen Investment
Target RWE, a clinical data company based in Durham, didn’t have to go far to find a strategic partner to boost its analytical prowess.
The company has acquired NoviSci, a software analysis and services company located in downtown Durham, seven miles away, while also scoring an investment in the newly combined company from California biotech pioneer Amgen.
“With the addition of NoviSci’s novel analytics platform and experienced team, Target provides a highly adaptive environment to accelerate insights and reproducible research output from real-world data to various stakeholders in the healthcare ecosystem, including our pharmaceutical industry partners, healthcare investigator partners, government agencies and payor organizations,” Neal Bibeau, chief executive officer of Target RWE, said in a news release.